Free Trial

AGF Management Ltd. Purchases New Position in agilon health, inc. (NYSE:AGL)

→ Elon to Transform U.S. Economy? (From Porter & Company) (Ad)
agilon health logo with Medical background

AGF Management Ltd. bought a new stake in agilon health, inc. (NYSE:AGL - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 243,589 shares of the company's stock, valued at approximately $3,057,000. AGF Management Ltd. owned 0.06% of agilon health as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Signaturefd LLC lifted its position in agilon health by 73.7% during the third quarter. Signaturefd LLC now owns 1,673 shares of the company's stock valued at $30,000 after purchasing an additional 710 shares in the last quarter. Arizona State Retirement System lifted its position in shares of agilon health by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 86,455 shares of the company's stock valued at $1,535,000 after buying an additional 1,169 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of agilon health by 17.9% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,452 shares of the company's stock valued at $274,000 after acquiring an additional 2,349 shares during the period. Van ECK Associates Corp increased its holdings in agilon health by 164.7% in the 3rd quarter. Van ECK Associates Corp now owns 4,111 shares of the company's stock worth $73,000 after acquiring an additional 2,558 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. raised its stake in agilon health by 128.6% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 6,820 shares of the company's stock worth $121,000 after acquiring an additional 3,837 shares during the period.


Analyst Ratings Changes

A number of research firms have weighed in on AGL. Stifel Nicolaus dropped their price target on shares of agilon health from $8.00 to $7.00 and set a "hold" rating for the company in a research report on Wednesday, May 1st. Royal Bank of Canada decreased their price target on agilon health from $11.00 to $8.00 and set an "outperform" rating on the stock in a report on Wednesday, February 28th. Evercore ISI dropped their price objective on agilon health from $7.00 to $6.00 and set an "in-line" rating for the company in a research note on Wednesday, February 28th. Benchmark decreased their target price on agilon health from $13.00 to $9.00 and set a "buy" rating on the stock in a research note on Thursday, February 29th. Finally, Citigroup began coverage on agilon health in a report on Monday, April 22nd. They issued a "neutral" rating and a $6.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $9.32.

Read Our Latest Stock Analysis on AGL

agilon health Price Performance

Shares of NYSE AGL traded up $0.29 during mid-day trading on Tuesday, hitting $5.50. 6,223,437 shares of the company's stock traded hands, compared to its average volume of 5,543,282. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.33 and a quick ratio of 1.33. agilon health, inc. has a 1 year low of $4.41 and a 1 year high of $24.15. The company's 50-day moving average is $5.28 and its two-hundred day moving average is $8.31. The company has a market capitalization of $2.26 billion, a P/E ratio of -7.86 and a beta of 0.52.

agilon health (NYSE:AGL - Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.28) by ($0.13). The company had revenue of $1.06 billion for the quarter, compared to analysts' expectations of $1.02 billion. agilon health had a negative net margin of 5.67% and a negative return on equity of 26.15%. The company's revenue for the quarter was up 71.8% on a year-over-year basis. During the same quarter last year, the company earned ($0.14) earnings per share. On average, equities analysts anticipate that agilon health, inc. will post -0.34 EPS for the current fiscal year.

agilon health Company Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

→ RSVP: Charles Payne’s Cash Flow Workshop (From Unstoppable Prosperity) (Ad)

Should you invest $1,000 in agilon health right now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy or Bail? Stock Upgrades and Downgrades
Profit Like Congress: The Stocks They’re Betting On
Cathie Wood’s AMD Buy: Smart Move or Risky Business

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines